ENZC (Enzolytics) Total Liabilities: $0.80 Mil (As of Jun. 2011)


What is Enzolytics Total Liabilities?

Enzolytics ENZC Total Liabilities is $0.80 Mil as of Jun. 2011.

Enzolytics's Total Liabilities for the quarter that ended in Jun. 2011 was $0.80 Mil.

Enzolytics's quarterly Total Liabilities increased from Dec. 2010 ($0.73 Mil) to Mar. 2011 ($0.80 Mil) and increased from Mar. 2011 ($0.80 Mil) to Jun. 2011 ($0.80 Mil).

Enzolytics's annual Total Liabilities increased from Jul. 2008 ($0.08 Mil) to Dec. 2009 ($1.41 Mil) but then declined from Dec. 2009 ($1.41 Mil) to Dec. 2010 ($0.73 Mil).

Enzolytics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Enzolytics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics Total Liabilities Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
Total Liabilities
0.44 0.08 1.41 0.73

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.90 2.02 0.73 0.80 0.80

Enzolytics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Enzolytics's Total Liabilities for the fiscal year that ended in Dec. 2010 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.677+(0.048+-6.9388939039072E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.73

Total Liabilities=Total Assets (A: Dec. 2010 )-Total Equity (A: Dec. 2010 )
=0.153--0.572
=0.73

Enzolytics's Total Liabilities for the quarter that ended in Jun. 2011 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.778+(0.024+0.001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.80

Total Liabilities=Total Assets (Q: Jun. 2011 )-Total Equity (Q: Jun. 2011 )
=0.112--0.691
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.80 Mil mean?
Enzolytics (ENZC) has a Total Liabilities of $0.80 Mil as of Jun. 2011. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Enzolytics and its competitors.
Is Enzolytics' Total Liabilities too high?
Enzolytics' current Total Liabilities is $0.80 Mil.
How does Enzolytics' Total Liabilities compare to competitors?
Enzolytics' Total Liabilities of $0.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Enzolytics and its competitors. Enzolytics's current Total Liabilities is $0.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current Total Liabilities of $0.80 Mil. The current Total Liabilities is $0.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Enzolytics (ENZC), the current Total Liabilities is $0.80 Mil as of Jun. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.